Aridis Pharmaceuticals Price Prediction
At this time the relative strength index (rsi) of Aridis Pharmaceuticals' share price is below 20 . This suggests that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of Aridis Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Aridis Pharmaceuticals and does not consider all of the tangible or intangible factors available from Aridis Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Aridis Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Aridis Pharmaceuticals hype-based prediction, you can estimate the value of Aridis Pharmaceuticals from the perspective of Aridis Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aridis Pharmaceuticals to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Aridis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Aridis Pharmaceuticals after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Aridis |
| Symbol | ARDS |
| Name | Aridis Pharmaceuticals |
| Type | Pink Sheet |
| Country | United States |
| Exchange | PINK |
Hype Analysis is not found for Aridis Pharmaceuticals at this timeWe are unable to locate Aridis Pharmaceuticals hype analysis at this time. If you believe the equity you are trying to look up is valid, please let us know, and we will check it out.Hype Analysis
Prediction analysis is currently not available
Other Suggestions
| AR | Antero Resources Corp | Company |
| AR | Arweave | Cryptocurrency |
| ARR-PC | ARMOUR Residential REIT | Company |
| ARDC | Ares Dynamic Credit | Fund |
| ARB | AltShares Trust | ETF |
Thematic Opportunities
Explore Investment Opportunities
Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Aridis Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Aridis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aridis using various technical indicators. When you analyze Aridis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Story Coverage note for Aridis Pharmaceuticals
The number of cover stories for Aridis Pharmaceuticals depends on current market conditions and Aridis Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aridis Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aridis Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Aridis Pharmaceuticals Short Properties
Aridis Pharmaceuticals' future price predictability will typically decrease when Aridis Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aridis Pharmaceuticals often depends not only on the future outlook of the potential Aridis Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aridis Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 27 M | |
| Cash And Short Term Investments | 4.9 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Aridis Pink Sheet
If you are still planning to invest in Aridis Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aridis Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |